additionally determined that BC cells resistant to trastuzumab exhibit the upregulation of circ-BGN, which contributes to this chemoresistance through its ability to directly bind OTUB1 and SLC7A11, thus inhibiting ferroptotic cell death via the enhancement of OTUB1-mediated SLC7A11 deubiquitination (83). Here, SLC7A11 is linked to breast cancer.